What is the next higher oral dose of Wegovy (semaglutide) after the initial 1.5 mg tablet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Oral Wegovy Dosing: There is No 1.5 mg Tablet

Oral Wegovy (semaglutide) does not exist as a 1.5 mg tablet formulation. You appear to be confusing the subcutaneous (injectable) Wegovy dosing schedule with an oral formulation that has entirely different dosing.

Critical Clarification: Two Different Formulations

Subcutaneous (Injectable) Wegovy

The injectable form follows this escalation schedule 1:

  • Week 1-4: 0.25 mg once weekly
  • Week 5-8: 0.5 mg once weekly
  • Week 9-12: 1.0 mg once weekly
  • Week 13-16: 1.7 mg once weekly
  • Week 17+: Maintenance dose of 2.4 mg once weekly (or 1.7 mg if 2.4 mg not tolerated)

Oral Wegovy (Recently Approved)

The oral formulation uses completely different dosing 2:

  • 25 mg once daily (lower dose option)
  • 50 mg once daily (standard dose)

These are taken daily, not weekly, and must be taken in the fasting state with no more than 120 mL of plain water, at least 30 minutes before any food, beverages, or other oral medications 3, 4.

Common Pitfall to Avoid

Do not attempt to convert or compare injectable and oral semaglutide doses directly. The oral formulation has only ~1% bioavailability compared to ~89% for subcutaneous administration 5, 6. The 50 mg oral dose achieves similar exposure levels to the 2.4 mg subcutaneous dose, but they are not interchangeable 7.

If You're Prescribing Oral Semaglutide for Diabetes (Rybelsus)

The oral formulation for diabetes follows a different escalation 3:

  • Start: 3 mg once daily for 30 days
  • Next dose: 7 mg once daily
  • Maximum: 14 mg once daily (if additional glycemic control needed after 30 days on 7 mg)

The answer to your question depends on which formulation you're actually using—there is no 1.5 mg oral tablet in any semaglutide product.

References

Related Questions

What higher dose of semaglutide is available beyond the approved 2 mg weekly dose for a patient who wants to increase therapy?
Is oral semaglutide appropriate for weight loss in an adult patient with obesity without type 2 diabetes, and what is the recommended dosing regimen?
Can I switch a patient from oral semaglutide (Rybelsus) to injectable semaglutide (Wegovy) for weight‑loss treatment?
Does Wegovy (semaglutide) have an SNAC coating?
Is there an oral formulation of Wegovy (semaglutide) for weight loss, and what is the recommended dosing regimen?
What are the likely causes of acute pericarditis in a 21-year-old woman without renal disease, recent cardiac surgery, or known autoimmune disorder?
Is the regimen of Invega Haffera (paliperidone palmitate) 1092 mg intramuscularly every six months, Wellbutrin XL (bupropion) 450 mg daily, propranolol 20 mg twice daily, and clonazepam 1 mg daily as needed appropriate and safe for a patient with schizophrenia, depression, and anxiety?
In a hypovolemic patient with postural orthostatic tachycardia syndrome (POTS), does increased dehydration cause greater heart‑rate increase and variability on standing and worsen gastrointestinal symptoms such as nausea?
What urine output would you expect in a patient with a glomerular filtration rate of 9 mL/min (end‑stage renal disease)?
How do I start and dose Novolog (insulin aspart) for an adult with type 1 or type 2 diabetes, and what are the storage requirements?
In a 24-year-old male with mental health disorder, plaque psoriasis, bilateral lower extremity amputations, severe muscle deconditioning, bronchiectasis, protein‑calorie malnutrition, and a QTc of 387 ms who is currently taking escitalopram 10 mg with inadequate response, what are the contraindications to initiating mirtazapine and what is the safest transition plan?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.